VitaNova Life Sciences (VNOV) Shares Outstanding (2018 - 2026)

VitaNova Life Sciences has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $8.3 million for Q3 2026.

• Shares Outstanding (Entity) for Q3 2026 came in at $8.3 million, down 66.67% year-over-year; the trailing twelve-month figure through Jul 2026 was $8.3 million (down 66.67% YoY), and the FY2026 annual result was $8.3 million, down 66.67% from the prior year.
• Shares Outstanding (Entity) for Q3 2026 stood at $8.3 million, roughly flat from $8.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $25.0 million in Q3 2024 and bottomed at $5.9 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $12.6 million, with a median of $8.3 million recorded in 2026.
• The widest annual swing landed in 2024, when Shares Outstanding (Entity) soared 326.01%; it then sank 66.67% in 2026.
• Year by year, Shares Outstanding (Entity) stood at $5.9 million in 2022, then changed by 0.0% to $5.9 million in 2023, then surged by 326.01% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025, then plunged by 66.67% to $8.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $8.3 million (Q3 2026), $8.3 million (Q2 2026), and $8.3 million (Q1 2026), per Business Quant data.